FDA inspection
SCA Pharmaceuticals, Inc.: FDA inspection ending Oct 30, 2025
FDA inspection 1281852 · Official Action Indicated (OAI) · Little Rock, AR
Key facts
| Inspection ID | 1281852 |
|---|---|
| Firm | SCA Pharmaceuticals, Inc. |
| FEI number | 3010683157 |
| Address | 8821 Knoedl Ct |
| City | Little Rock |
| State | AR |
| ZIP | 72205 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Oct 30, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 724202 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data